½ÃÀ庸°í¼­
»óǰÄÚµå
1625236

¹Ì¼¼Á¶·ù ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çü, Ä«Å×°í¸®, ÇüÅÂ, µî±Þ, ¿ëµµ, À¯Åë ä³Î, Áö¿ªº° ¼¼°è ºÐ¼®

Microalgae Market Forecasts to 2030 - Global Analysis By Type (Spirulina, Chlorella, Haematococcus Pluvialis, Dunaliella Salina and Other Types), Category (Organic and Inorganic), Form, Grade, Application, Distribution Channel and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀåÀº 2024³â¿¡ 127¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß 8.4%ÀÇ CAGR·Î ¼ºÀåÇϸç, 2030³â±îÁö 207¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

¹Ì¼¼Á¶·ù´Â ´ã¼ö ¹× ÇØ¾ç ¼­½ÄÁö¿¡¼­ °¡Àå ÀÛÀº ±¤ÇÕ¼ºÀ» ÇÏ´Â µ¿¹°·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ÀÌ »ý¹°Àº »ýŰèÀÇ ±âº» Á¸Àç·Î »ê¼Ò¸¦ »ý»êÇÏ°í ¼ö»ý ¸ÔÀ̻罽ÀÇ ±âº» À§Ä¡¸¦ Â÷ÁöÇÕ´Ï´Ù. ¿µ¾ç°¡°¡ ³ô°í Àç»ýÇÑ ¹ÙÀÌ¿À¿¬·á, ¿µ¾ç º¸ÃæÁ¦, È­Àåǰ, ÀǾàǰÀÇ ¿ø·á·Î ½±°Ô º¸ÃæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ»êȭź¼Ò¸¦ °íÁ¤ÇÒ ¼ö ÀÖ´Â ¹Ì¼¼Á¶·ù´Â ±âÈÄ º¯È­¸¦ ¿ÏÈ­ÇÏ´Â µ¥ ±â¿©Çϰí ȯ°æ°ú »ê¾÷ ÀÀ¿ë¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¹Ì±¹ ¿¡³ÊÁöºÎ(DOE)¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¹Ì¼¼Á¶·ù ¹ÙÀÌ¿À¸Å½º »ý»ê °¡´É·®Àº ¿¬°£ 1¾ï 5,200¸¸ Åæ(¹«È¸ °ÇÁ¶ Áß·®)À¸·Î ÃßÁ¤µË´Ï´Ù.

°Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü

¼ÒºñÀÚµéÀÇ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¹Ì¼¼Á¶·ù ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¹Ì¼¼Á¶·ù´Â ´Ü¹éÁú, ºñŸ¹Î, ¿À¸Þ°¡ 3 Áö¹æ»ê µî Çʼö ¿µ¾ç¼Ò¸¦ dzºÎÇÏ°Ô ÇÔÀ¯Çϰí ÀÖÀ¸¸ç, °Ç°­º¸Á¶½Äǰ ¹× ±â´É¼º ½ÄǰÀ¸·Î ÀαⰡ ³ô½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ½Ä¹°¼º ½Ä´Ü ¹× õ¿¬ ½Äǰ Àç·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¹Ì¼¼Á¶·ùÀÇ °Ç°­ È¿°ú¿¡ ´ëÇÑ ÀνÄÀÌ °è¼Ó ³ô¾ÆÁü¿¡ µû¶ó ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼­ ¹Ì¼¼Á¶·ù Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³ôÀº »ý»ê ºñ¿ë

³ôÀº »ý»êºñ¿ëÀº ¿©ÀüÈ÷ ¹Ì¼¼Á¶·ù ½ÃÀåÀÇ Å« ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ì¼¼Á¶·ù Àç¹è ¹× °¡°øÀº ÷´Ü ±â¼ú, ÅëÁ¦µÈ ȯ°æ, »ó´çÇÑ ¿¡³ÊÁö ÅõÀÔÀÌ ÇÊ¿äÇϸç, ÀÌ´Â ¿î¿µ ºñ¿ë Áõ°¡·Î À̾îÁý´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ëÀº Á¾Á¾ ¼ÒºñÀÚ¿¡°Ô Àü°¡µÇ¸ç, ƯÈ÷ °¡°Ý¿¡ ¹Î°¨ÇÑ Áö¿ª¿¡¼­ ½ÃÀå ħÅõ¸¦ Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ±Øº¹ÇÏ°í ½ÃÀåÀ» È®´ëÇϱâ À§Çؼ­´Â ±â¼ú ¹ßÀü°ú ±Ô¸ðÀÇ °æÁ¦¸¦ ÅëÇÑ »ý»ê ºñ¿ë Àý°¨ÀÌ ÇʼöÀûÀÔ´Ï´Ù.

ÀǾàǰ ¹× È­Àåǰ ºÐ¾ß·Î È®´ë

¹Ì¼¼Á¶·ù°¡ ÀǾàǰ ¹× È­Àåǰ¿¡ Àû¿ëµÇ´Â ¹üÀ§°¡ È®´ëµÇ¸é¼­ ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. Ç×»êÈ­Á¦, »ý¸®È°¼º ÆéƼµå µî ¹Ì¼¼Á¶·ù¿¡¼­ ÃßÃâÇÑ È­ÇÕ¹°Àº ³ëÈ­ ¹æÁö ¹× Ä¡À¯ È¿°ú·Î ÀÎÇØ ½ºÅ²Äɾî Á¦Ç° ¹× Ä¡·áÁ¦¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¾ß¿¡¼­ õ¿¬ ¹× Áö¼Ó°¡´ÉÇÑ ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹Ì¼¼Á¶·ù ±â¹Ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±â¼ú Çõ½Å°ú ÅõÀÚ°¡ ´õ¿í ÃËÁøµÇ°í ÀÖÀ¸¸ç, ½ÃÀå È®´ëÀÇ »õ·Î¿î °æ·Î¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

Ç¥ÁØÈ­ ºÎÁ·

¹Ì¼¼Á¶·ù ¹è¾ç, °¡°ø ¹× ǰÁú Æò°¡ÀÇ Ç¥ÁØÈ­ ºÎÁ·Àº ½ÃÀå¿¡ Å« À§ÇùÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Á¦Ç° ǰÁúÀÇ ÆíÂ÷´Â ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ¶³¾î¶ß¸®°í, ƯÈ÷ ½Äǰ ¹× ÀǾàǰ¿¡ Àû¿ëµÉ ¶§ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Ç¥ÁØÈ­µÈ °üÇà°ú ÀÎÁõÀ» È®¸³ÇÏ´Â °ÍÀº Àϰü¼ºÀ» º¸ÀåÇϰí, Á¦Ç°ÀÇ ½Å·Ú¼ºÀ» ³ôÀ̸ç, ¾÷°è Àü¹Ý¿¡ °ÉÃÄ ¹Ì¼¼Á¶·ù À¯·¡ Á¦Ç°ÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

COVID-19 ÆÒµ¥¹ÍÀº ¼ÒºñÀÚµéÀÌ °Ç°­°ú ¸é¿ª·ÂÀ» °­È­ÇÏ´Â Á¦Ç°À» Á¡Á¡ ´õ ¿ì¼±½ÃÇÏ°Ô µÇ¸é¼­ ¹Ì¼¼Á¶·ù ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ ±â°£ Áß ¹Ì¼¼Á¶·ù°¡ ÇÔÀ¯µÈ °Ç°­º¸Á¶½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ¶ÇÇÑ ÀüÅëÀûÀÎ ½Äǰ °ø±Þ¸ÁÀÇ È¥¶õÀº ¹Ì¼¼Á¶·ù¿Í °°Àº ´ëü ´Ü¹éÁú °ø±Þ¿øÀÇ ÀáÀç·ÂÀ» °­Á¶Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ¹Ì¼¼Á¶·ù ±â¹Ý Á¦Ç°ÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ¾ú½À´Ï´Ù.

¿¹Ãø ±â°£ Áß ½Äǰ ¹× À½·á ºÐ¾ß°¡ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì¼¼Á¶·ù´Â °Ç°­½Äǰ, À½·á, °Ç°­º¸Á¶½ÄǰÀÇ ±â´É¼º ¼ººÐÀ¸·Î »ç¿ëµÇ´Â °æ¿ì°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½Äǰ ¹× À½·á ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ôÀº ¿µ¾ç°¡ ´öºÐ¿¡ õ¿¬ ½Ä¹°¼º Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â ÀÌ»óÀûÀÎ ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ¹Ì¼¼Á¶·ù¸¦ ÁÖ·ù ½Äǰ ¿ëµµ¿¡ ÅëÇÕÇϱâ À§ÇÑ ±â¼ú Çõ½Å¿¡ ÀÇÇØ ´õ¿í ÃËÁøµÉ °ÍÀÔ´Ï´Ù.

Ŭ·Î·¼¶ó ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ŭ·Î·¼¶ó ºÎ¹®Àº ÇØµ¶, ¸é¿ª·Â °­È­, ¼ÒÈ­ °³¼± µî ´Ù¾çÇÑ °Ç°­»óÀÇ ÀÌÁ¡À¸·Î ÀÎÇØ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³ôÀº ´Ü¹éÁú ÇÔ·®À¸·Î ÀÎÇØ ä½ÄÁÖÀÇÀÚÀÇ ½Ä´Ü¿¡ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÄÀÌ º¸Á¶Á¦, È­Àåǰ, »ç·á¿¡ Ŭ·Î·¼¶óÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´Ù¾çÇÑ ¿ëµµ·ÎÀÇ ¹ü¿ë¼º°ú ±Þ°ÝÇÑ ¼ºÀå ÀáÀç·ÂÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» °¡Áø Áö¿ª :

¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àß È®¸³µÈ ¾ç½Ä »ê¾÷°ú Á¶·ù ±â¹Ý Á¦Ç°ÀÇ ³ôÀº ¼Òºñ·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, ÀϺ», Àεµ¿Í °°Àº ±¹°¡µéÀº ±â´É¼º ½Äǰ, ¿µ¾ç º¸ÃæÁ¦, È­Àåǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾Æ ÀÌ Áö¿ªÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áö¼Ó°¡´ÉÇÑ ³ó¾÷À» Àå·ÁÇÏ´Â Á¤ºÎÀÇ ±¸»óÀº ÀÌ Áö¿ª ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

ºÏ¹Ì´Â ¹Ì¼¼Á¶·ù¿Í °ü·ÃµÈ °Ç°­»óÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ½Ä¹°¼º ´Ü¹éÁú ¹× õ¿¬ ¼ÒÀç¿¡ ´ëÇÑ ¼ö¿ä°¡ °­ÇØ ½Äǰ ¹× À½·á ¹× °Ç°­ º¸Á¶ ½ÄǰÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹è¾ç ±â¼úÀÇ ¹ßÀüÀº ºÏ¹Ì ½ÃÀåÀÇ ºü¸¥ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. :

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ Á¾ÇÕ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3»ç)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¿ªÀû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç ¾îÇÁ·ÎÄ¡
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : À¯Çüº°

  • ½ºÇǷ긮³ª
  • Ŭ·Î·¼¶ó
  • Haematococcus Pluvialis
  • Dunaliella Salina
  • Isochrysis
  • Phaeodactylum Tricornutum
  • Chlamydomonas Cruentum
  • Nannochloropsis
  • ±âŸ À¯Çü

Á¦6Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : Ä«Å×°í¸®º°

  • À¯±â
  • ¹«±â

Á¦7Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : Çüź°

  • ÆÄ¿ì´õ/µå¶óÀÌ
  • ¾×ü

Á¦8Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : µî±Þº°

  • ½Äǰ µî±Þ
  • È­Àåǰ µî±Þ
  • »ç·á µî±Þ
  • ¿¬·á µî±Þ
  • ±âŸ µî±Þ

Á¦9Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : ¿ëµµº°

  • ½ÄÀ̺¸ÃæÁ¦
  • È­Àåǰ¡¤ÆÛ½º³ÎÄɾî
  • ½Äǰ ¹× À½·á
  • ÀǾàǰ
  • µ¿¹° »ç·á
  • ¹ÙÀÌ¿À¿¬·á
  • À×Å©
  • ±âŸ ¿ëµµ

Á¦10Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : À¯Åë ä³Îº°

  • Á÷Á¢ ÆÇ¸Å
  • °£Á¢ ÆÇ¸Å

Á¦11Àå ¼¼°èÀÇ ¹Ì¼¼Á¶·ù ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕº´»ç¾÷
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • DIC Corporation
  • Cyanotech Corporation
  • Corbion N.V.
  • AlgaEnergy S.A.
  • Cellana Inc.
  • Euglena Co., Ltd.
  • Algaecytes
  • Parry Nutraceuticals
  • Allmicroalgae
  • Kuehnle AgroSystems
  • Algatech
  • Algarithm
  • Sunrise Nutrachem Group Co., Ltd.
  • BASF SE
  • Koninklijke DSM N.V.
  • Solabia Group
  • TerraVia Holdings, Inc.
  • Roquette Freres
KSA 25.01.23

According to Stratistics MRC, the Global Microalgae Market is accounted for $12.7 billion in 2024 and is expected to reach $20.7 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Microalgae are considered the smallest, photosynthetic animals in freshwater and marine habitats. These organisms are basics to ecological systems, capable of producing oxygen and holding a basic position in the aquatic food webs. They are highly nutrient-rich and they can easily be replenished as a raw material for renewable biofuels, dietary supplements, cosmetics, and pharmaceuticals. Capable of carbon dioxide fixation, microalgae contribute to climate change mitigation, making them vital for environmental and industrial applications.

According to the U.S. Department of Energy (DOE), the total microalgae biomass production potential in the United States is estimated at 152 million tons per year (ash-free dry weight).

Market Dynamics:

Driver:

Increasing health consciousness

The rising health consciousness among consumers has significantly driven the microalgae market. Microalgae are rich in essential nutrients, including proteins, vitamins, and omega-3 fatty acids, making them a popular choice for health supplements and functional foods. This trend is further supported by the growing preference for plant-based diets and natural food ingredients. As awareness of the health benefits of microalgae continues to grow, demand for these products is expected to rise across various industries.

Restraint:

High production costs

High production costs remain a significant restraint for the microalgae market. Cultivating and processing microalgae require advanced technologies, controlled environments, and substantial energy inputs, leading to increased operational expenses. These costs are often passed on to consumers, limiting market penetration, particularly in price-sensitive regions. Reducing production costs through technological advancements and economies of scale is essential to overcoming this challenge and expanding the market.

Opportunity:

Expansion in pharmaceuticals and cosmetics

The growing application of microalgae in pharmaceuticals and cosmetics presents a lucrative opportunity for market growth. Microalgae-derived compounds, such as antioxidants and bioactive peptides, are increasingly used in skincare products and therapeutic formulations due to their anti-aging and healing properties. The rising demand for natural and sustainable ingredients in these sectors further drives innovation and investment in microalgae-based solutions, creating new avenues for market expansion.

Threat:

Lack of standardization

The lack of standardization in microalgae cultivation, processing, and quality assessment poses a significant threat to the market. Variability in product quality can undermine consumer trust and hinder regulatory approvals, especially in food and pharmaceutical applications. Establishing standardized practices and certifications is critical to ensuring consistency, enhancing product credibility, and fostering wider adoption of microalgae-derived products across industries.

Covid-19 Impact:

The COVID-19 pandemic positively impacted the microalgae market as consumers increasingly prioritized health and immunity-boosting products. The demand for dietary supplements containing microalgae surged during this period. Additionally, disruptions in traditional food supply chains highlighted the potential of alternative protein sources like microalgae. These factors collectively accelerated the adoption of microalgae-based products across various sectors.

The food & beverages segment is expected to be the largest during the forecast period

The food & beverages segment is expected to dominate the market due to the increasing use of microalgae as a functional ingredient in health foods, beverages, and dietary supplements. Its high nutritional value makes it an ideal choice for addressing consumer demand for natural and plant-based products. The segment's growth is further driven by innovations in incorporating microalgae into mainstream food applications.

The chlorella segment is expected to have the highest CAGR during the forecast period

The chlorella segment is expected to witness the highest CAGR due to its extensive health benefits, including detoxification, immune support, and improved digestion. Its high protein content also makes it a preferred choice for vegan diets. The increasing use of chlorella in dietary supplements, cosmetics, and animal feed highlights its versatility and potential for rapid growth across multiple applications.

Region with largest share:

Over the forecast period, the Asia Pacific region is anticipated to account for the largest market share due to its well-established aquaculture industry and high consumption of algae-based products. Countries like China, Japan, and India drive regional growth through their strong demand for functional foods, dietary supplements, and cosmetics. Additionally, government initiatives promoting sustainable agriculture further support market expansion in this region.

Region with highest CAGR:

The North America region is anticipated to register the highest growth rate over the forecast period owing to increasing consumer awareness about health benefits associated with microalgae. The region's robust demand for plant-based proteins and natural ingredients drives innovation in food & beverages as well as nutraceuticals. Moreover, advancements in cultivation technologies contribute to the rapid growth of this market in North America.

Key players in the market

Some of the key players in Microalgae Market include DIC Corporation, Cyanotech Corporation, Corbion N.V., AlgaEnergy S.A., Cellana Inc., Euglena Co., Ltd., Algaecytes, Parry Nutraceuticals, Allmicroalgae, Kuehnle AgroSystems, Algatech, Algarithm, Sunrise Nutrachem Group Co., Ltd., BASF SE, Koninklijke DSM N.V., Solabia Group, TerraVia Holdings, Inc. and Roquette Freres.

Key Developments:

In August 2024, Euglena Co., Ltd. signs with Petronas Research Sdn. Bhd. a subsidiary of Petroliam Nasional Berhad (hereafter "Petronas Research") that have entered into a Joint Development Agreement on August 21st , 2024 to implement a joint research with a mission to materialize the future large-scale commercial production of microalgae oil for SAF and other biofuels.

In July 2024, Parry Nutraceuticals, a division of EID Parry (I) Ltd, based in Chennai, has become a world leader and expert in micro-algal technology. Parry is the only micro-algal innovator in the world producing all three microalgae-spirulina, haematococcus (astaxanthin), and chlorella. The company works with ecologically sustainable cultivation practices that help preserve nutrients for optimum absorption.

In March 2024, Kuehnle AgroSystems ("KAS"), a leading microalgal innovation and production company, today announced that it has raised a $3 million Series A2 funding round led by S2G Ventures. The funding will accelerate the commercialization of KAS's pioneering method for producing natural astaxanthin from microalgae, a key component in sustainable aquaculture systems as well as a clinically proven human nutraceutical.

Types Covered:

  • Spirulina
  • Chlorella
  • Haematococcus Pluvialis
  • Dunaliella Salina
  • Isochrysis
  • Phaeodactylum Tricornutum
  • Chlamydomonas Cruentum
  • Nannochloropsis
  • Other Types

Categories Covered:

  • Organic
  • Inorganic

Forms Covered:

  • Powder/Dry
  • Liquid

Grades Covered:

  • Food Grade
  • Cosmetic Grade
  • Feed Grade
  • Fuel Grade
  • Other Grades

Applications Covered:

  • Dietary Supplements
  • Cosmetics & Personal Care
  • Food & Beverages
  • Pharmaceuticals
  • Animal Feed
  • Bio-Fuel
  • Inks
  • Other Applications

Distribution Channels Covered:

  • Direct
  • Indirect

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microalgae Market, By Type

  • 5.1 Introduction
  • 5.2 Spirulina
  • 5.3 Chlorella
  • 5.4 Haematococcus Pluvialis
  • 5.5 Dunaliella Salina
  • 5.6 Isochrysis
  • 5.7 Phaeodactylum Tricornutum
  • 5.8 Chlamydomonas Cruentum
  • 5.9 Nannochloropsis
  • 5.10 Other Types

6 Global Microalgae Market, By Category

  • 6.1 Introduction
  • 6.2 Organic
  • 6.3 Inorganic

7 Global Microalgae Market, By Form

  • 7.1 Introduction
  • 7.2 Powder/Dry
  • 7.3 Liquid

8 Global Microalgae Market, By Grade

  • 8.1 Introduction
  • 8.2 Food Grade
  • 8.3 Cosmetic Grade
  • 8.4 Feed Grade
  • 8.5 Fuel Grade
  • 8.6 Other Grades

9 Global Microalgae Market, By Application

  • 9.1 Introduction
  • 9.2 Dietary Supplements
  • 9.3 Cosmetics & Personal Care
  • 9.4 Food & Beverages
  • 9.5 Pharmaceuticals
  • 9.6 Animal Feed
  • 9.7 Bio-Fuel
  • 9.8 Inks
  • 9.9 Other Applications

10 Global Microalgae Market, By Distribution Channel

  • 10.1 Introduction
  • 10.2 Direct
  • 10.3 Indirect

11 Global Microalgae Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 DIC Corporation
  • 13.2 Cyanotech Corporation
  • 13.3 Corbion N.V.
  • 13.4 AlgaEnergy S.A.
  • 13.5 Cellana Inc.
  • 13.6 Euglena Co., Ltd.
  • 13.7 Algaecytes
  • 13.8 Parry Nutraceuticals
  • 13.9 Allmicroalgae
  • 13.10 Kuehnle AgroSystems
  • 13.11 Algatech
  • 13.12 Algarithm
  • 13.13 Sunrise Nutrachem Group Co., Ltd.
  • 13.14 BASF SE
  • 13.15 Koninklijke DSM N.V.
  • 13.16 Solabia Group
  • 13.17 TerraVia Holdings, Inc.
  • 13.18 Roquette Freres
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦